Silver Book Fact

A study exploring the decline in deaths attributable to cardiovascular disease in the U.S. from 1980 to 2000 suggested that approximately 47% of the decrease was due to the increased use of evidence-based medical therapies. 44% was due to changes in the risk factors of the population attributable to lifestyle and environmental changes.

Ford E, Ajani U, Croft J, Critchely J, et al. Explaining the Decrease in US Deaths from Coronary Disease, 1980-2000. N Engl J Med. 2007; 356: 2388-98. http://www.nejm.org/doi/full/10.1056/NEJMsa053935

Reference

Title
Explaining the Decrease in US Deaths from Coronary Disease, 1980-2000
Publication
N Engl J Med
Publication Date
2007
Authors
Ford E, Ajani U, Croft J, Critchely J, et al.
Pages
2388-98
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Improvements in QoL from TAVR in SAS patients
    Symptomatic aortic stenosis (SAS) patients who underwent transcatheter aortic valve replacement (TAVR) experienced quality of life (QoL) improvements from 5.3 at baseline (10 point scale with 10=best imaginable health state)…  
  • Anti-platelet therapy stroke risk reduction
    Anti-platelet therapy after a stroke or TIA reduces the risk of nonfatal ischemic strokes by 28% and fatal strokes by 16%.  
  • Initiating and continuing beta-blocker use in most first-time heart attack survivors for 20 years would result in 72,000 fewer coronary heart disease deaths, 62,000 fewer heart attacks, and 447,000 gained…  
  • Compared to predicted levels in the absence of drug therapy, there were 9% fewer deaths from major cardiovascular disease in 2001 and 38% and 25% fewer hospital discharges for stroke…  
  • Stroke rates among Afib patients
    In one year, 58,283 of the 1.265 million Medicare beneficiaries with atrial fibrillation that did not receive prophylaxis suffered a stroke. For those who did receive anti-coagulants, 38,468 suffered strokes.